Motor Cortical Neuromodulation for Interstitial Cystitis/Bladder Pain Syndrome

This study is testing if repetitive transcranial magnetic stimulation (rTMS) can help women with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). rTMS is a non-invasive treatment that uses magnetic fields to stimulate specific areas of the brain. Researchers believe that stimulating certain brain areas might help reduce pain and muscle activity in women with IC/BPS. You may be able to join if you are a woman at least 18 years old, have an IC/BPS diagnosis, and experience pelvic pain. The study will look at how much your pain changes over a shorter and longer period, and your overall response to the treatment. The current status of this study is unclear, and it plans to enroll 50 participants.

Study design
This interventional study plans to enroll 50 women. Participants will receive either active Repetitive Transcranial Magnetic Stimulation (rTMS) or a Sham Repetitive Transcranial Magnetic Stimulation (Sham-rTMS) device, which looks identical but does not stimulate the brain.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your pain will be measured from before the first treatment up to 3 weeks after the last treatment, and your overall response will be assessed 3 weeks after the last treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04734847

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome

Active, Not Recruiting
NAAges 18+InterventionalTreatment
University of Southern California
~50 participants
Updated 2026-06-17 on ClinicalTrials.gov
What's tested:Repetitive Transcranial Magnetic Stimulation (rTMS)Sham Repetitive Transcranial Magnetic Stimulation (Sham-rTMS)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Longer-term Pain
Measured over Before first treatment to 3 weeks after last treatment
+2 more outcomes measured
Interstitial Cystitis
Bladder Pain Syndrome
1 sites across 1 states
California1
  • Jason J Kutch, PhD · PRINCIPAL_INVESTIGATOR · University of Southern California

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Longer-term PainBefore first treatment to 3 weeks after last treatment

    Change in Visual Analog Scale of Pain. This scale ranges from 0 (no pain) to 10 (worst pain imaginable), so higher scores indicate more pain.

  • Shorter-term PainBefore first treatment to 1 day later just before second treatment

    Change in Visual Analog Scale of Pain. This scale ranges from 0 (no pain) to 10 (worst pain imaginable), so higher scores indicate more pain.

  • Global Response Assessment3 weeks after last treatment

    Global Response Assessment (GRA)